ACET
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
69.93M
39 days until earnings call
PTCHF
Price
$1.55
Change
-$0.27 (-14.84%)
Updated
Sep 2 closing price
Capitalization
407.69M
Interact to see
Advertisement

ACET vs PTCHF

Header iconACET vs PTCHF Comparison
Open Charts ACET vs PTCHFBanner chart's image
Adicet Bio
Price$0.84
Change-$0.00 (-0.00%)
Volume$2.32K
Capitalization69.93M
PureTech Health
Price$1.55
Change-$0.27 (-14.84%)
Volume$3K
Capitalization407.69M
ACET vs PTCHF Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. PTCHF commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and PTCHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ACET: $0.84 vs. PTCHF: $1.55)
Brand notoriety: ACET and PTCHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 29% vs. PTCHF: 53%
Market capitalization -- ACET: $69.83M vs. PTCHF: $407.69M
ACET [@Biotechnology] is valued at $69.83M. PTCHF’s [@Biotechnology] market capitalization is $407.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whilePTCHF’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • PTCHF’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than PTCHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 5 TA indicator(s) are bullish while PTCHF’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 5 bullish, 5 bearish.
  • PTCHF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PTCHF is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а +5.69% price change this week, while PTCHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

ACET is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($408M) has a higher market cap than ACET($69.9M). ACET YTD gains are higher at: -12.682 vs. PTCHF (-22.500). PTCHF has higher annual earnings (EBITDA): 37.8M vs. ACET (-112.08M). PTCHF has more cash in the bank: 322M vs. ACET (125M). ACET has less debt than PTCHF: ACET (15.4M) vs PTCHF (20.9M). PTCHF has higher revenues than ACET: PTCHF (6.17M) vs ACET (0).
ACETPTCHFACET / PTCHF
Capitalization69.9M408M17%
EBITDA-112.08M37.8M-297%
Gain YTD-12.682-22.50056%
P/E RatioN/A9.12-
Revenue06.17M-
Total Cash125M322M39%
Total Debt15.4M20.9M74%
FUNDAMENTALS RATINGS
ACET vs PTCHF: Fundamental Ratings
ACET
PTCHF
OUTLOOK RATING
1..100
1435
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9851
PRICE GROWTH RATING
1..100
4785
P/E GROWTH RATING
1..100
1730
SEASONALITY SCORE
1..100
2290

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (26) in the Medical Distributors industry is in the same range as PTCHF (43) in the null industry. This means that ACET’s stock grew similarly to PTCHF’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as PTCHF (100) in the null industry. This means that ACET’s stock grew similarly to PTCHF’s over the last 12 months.

PTCHF's SMR Rating (51) in the null industry is somewhat better than the same rating for ACET (98) in the Medical Distributors industry. This means that PTCHF’s stock grew somewhat faster than ACET’s over the last 12 months.

ACET's Price Growth Rating (47) in the Medical Distributors industry is somewhat better than the same rating for PTCHF (85) in the null industry. This means that ACET’s stock grew somewhat faster than PTCHF’s over the last 12 months.

ACET's P/E Growth Rating (17) in the Medical Distributors industry is in the same range as PTCHF (30) in the null industry. This means that ACET’s stock grew similarly to PTCHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETPTCHF
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNHVF21.42N/A
N/A
Mowi ASA
SMGBF1.00N/A
N/A
San Miguel Corp.
DSHKN8.00N/A
N/A
Drive Shack Inc.
KLKLF0.26N/A
N/A
KIRKLAND LAKE DISCOVERIES CORP.
ADSLF1.23N/A
N/A
Andean Silver Ltd

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with SYRE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+0.14%
SYRE - ACET
46%
Loosely correlated
+4.04%
IPSC - ACET
45%
Loosely correlated
+4.41%
RGNX - ACET
44%
Loosely correlated
+3.10%
ARWR - ACET
41%
Loosely correlated
+3.58%
INBX - ACET
40%
Loosely correlated
+2.25%
More

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and PHGE have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
PHGE - PTCHF
22%
Poorly correlated
+0.58%
BCTX - PTCHF
22%
Poorly correlated
+3.08%
ACET - PTCHF
20%
Poorly correlated
+0.14%
SBMFF - PTCHF
18%
Poorly correlated
N/A
RVXCF - PTCHF
10%
Poorly correlated
+3.69%
More